ara-290 vs bpc-157 ARA 290, a Nonerythropoietic Peptide Engineered from Erythropoietin, Improves Metabolic Control and Neuropathic Symptoms in Patients with Type 2 Diabetes Regenerative peptides | BPC-157, TB-500,

Subscription plans: Weekly or bi-weekly bundles, standard at Ivy Rx, lock in lower rates ($18$25/shot) and reduce overall spend by 10%, sometimes up to 150%

Elevating Healthcare Professional Education A common problem faced by PA patients is the adherence to a rigid, infrequent injection schedule (typically 1mg every 2-3 months)

One compound gaining attention is 5-Amino-1MQ, an investigational molecule being studied for its potential effects on NNMT activity, fat cell metabolism, insulin-related pathways, and broader metabolic health

At AgelessRx, we have taken the supplemental B12 injection and optimized it with methionine, inositol, and choline (hence the acronym MIC)

Final Insights The market for peptides is real, the clinical interest is real, and the regulatory window opening in 2026 will bring a new wave of founders trying to build in this space